about
Overview of healthcare in the UKWorld health dilemmas: Orphan and rare diseases, orphan drugs and orphan patientsCost-outcome description of clinical pharmacist interventions in a university teaching hospitalMechanism-based approach to the economic evaluation of pharmaceuticals: pharmacokinetic/pharmacodynamic/pharmacoeconomic analysis of rituximab for follicular lymphoma.Role of the pharmacist in reducing healthcare costs: current insights.Pharmacoeconomics
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
From NCE to NICE: the role of pharmacoeconomics.
@en
From NCE to NICE: the role of pharmacoeconomics.
@nl
type
label
From NCE to NICE: the role of pharmacoeconomics.
@en
From NCE to NICE: the role of pharmacoeconomics.
@nl
prefLabel
From NCE to NICE: the role of pharmacoeconomics.
@en
From NCE to NICE: the role of pharmacoeconomics.
@nl
P2860
P1476
From NCE to NICE: the role of pharmacoeconomics.
@en
P2860
P304
P356
10.1111/J.1365-2125.2010.03708.X
P407
P577
2010-09-01T00:00:00Z